The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection
about
Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondiiClinically Available Medicines Demonstrating Anti-Toxoplasma ActivityQuinupristin-dalfopristin is active against Toxoplasma gondiiTelithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatmentIn vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisIn vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii.Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca miceDrug target identification in protozoan parasites.In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin.Identification of potential apicoplast associated therapeutic targets in human and animal pathogen Toxoplasma gondii ME49.
P2860
Q24550659-51CF932D-6D87-4741-9FF1-61FAE40E234EQ26782581-E6243F65-7B07-4EB9-BA3E-2C9767A2BE92Q28343473-FAB5EB78-C3B1-4F9E-8AA4-04529D28B058Q28343803-6F4C96E9-3DCE-4A13-B923-374C6CD30FB3Q28344762-4E0A7E3B-3A77-4994-A3A5-19138B3131FBQ28365205-917403FE-1FAA-4FA9-A238-2867DE3F6A30Q34113944-A2902B42-9058-47C9-B721-2465B168511AQ35106186-1752014E-17C5-41FF-AC53-F296A8A25BD2Q38847814-5AD8FFFF-73FA-4635-9A65-E8661D0A6EA1Q39469546-4E904073-1DEF-4460-AF5A-986D89AF4838Q39651581-A44C3898-A816-4D43-A0F5-0C55936C7E60Q41158389-BE88363A-E870-4EBB-9406-4B3D69B2532E
P2860
The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The ketolide antibiotics HMR 3 ...... in murine models of infection
@ast
The ketolide antibiotics HMR 3 ...... in murine models of infection
@en
The ketolide antibiotics HMR 3 ...... in murine models of infection
@nl
type
label
The ketolide antibiotics HMR 3 ...... in murine models of infection
@ast
The ketolide antibiotics HMR 3 ...... in murine models of infection
@en
The ketolide antibiotics HMR 3 ...... in murine models of infection
@nl
prefLabel
The ketolide antibiotics HMR 3 ...... in murine models of infection
@ast
The ketolide antibiotics HMR 3 ...... in murine models of infection
@en
The ketolide antibiotics HMR 3 ...... in murine models of infection
@nl
P2093
P2860
P356
P1476
The ketolide antibiotics HMR 3 ...... in murine models of infection
@en
P2093
A Bryskier
F G Araujo
J S Remington
T L Slifer
P2860
P304
P356
10.1128/AAC.41.10.2137
P407
P577
1997-10-01T00:00:00Z